A biochemical mechanism for the oncogenic potential of the p110β catalytic subunit of phosphoinositide 3-kinase
2010
The Role of p110β in Cancer
publication
Evidence: moderate
Author Information
Author(s): Hashem A. Dbouk, Jonathan M. Backer
Primary Institution: Albert Einstein College of Medicine
Hypothesis
How does the regulation of p110β differ from p110α in tumorigenesis?
Conclusion
p110β is essential for tumorigenesis in PTEN-null models and has unique regulatory mechanisms that could inform cancer treatment.
Supporting Evidence
- p110β is oncogenic when expressed in its wild-type form.
- Loss of PTEN leads to high levels of PIP3 and uncontrolled signaling.
- p110β is essential for survival and has unique functions not shared with other PI3K subunits.
Takeaway
p110β is a special protein that helps some cancers grow, and understanding how it works can help doctors find better treatments.
Methodology
The study used assays to measure the regulation of p110β compared to other PI3K subunits.
Limitations
The study primarily focuses on p110β without extensive exploration of other PI3K isoforms.
Want to read the original?
Access the complete publication on the publisher's website